Arcadia Biosciences SG&A Expense (Quarterly) Insights

Arcadia Biosciences Inc (RKDA)

2.076 +0.10 (+4.82%) USD | NASDAQ | May 09, 16:00

2.04 -0.04 (-1.71%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	3.423M
September 30, 2023	3.443M
June 30, 2023	3.815M
March 31, 2023	4.392M
December 31, 2022	3.629M
September 30, 2022	4.178M
June 30, 2022	4.652M
March 31, 2022	4.349M
December 31, 2021	6.205M
September 30, 2021	6.312M
June 30, 2021	6.37M
March 31, 2021	4.069M
December 31, 2020	4.778M
September 30, 2020	4.292M
June 30, 2020	3.674M
March 31, 2020	3.723M
December 31, 2019	3.133M
September 30, 2019	4.477M
June 30, 2019	3.146M
March 31, 2019	2.812M
December 31, 2018	3.023M

Date	Value
September 30, 2018	3.011M
June 30, 2018	2.949M
March 31, 2018	2.621M
December 31, 2017	2.241M
September 30, 2017	2.415M
June 30, 2017	2.943M
March 31, 2017	3.052M
December 31, 2016	3.368M
September 30, 2016	2.687M
June 30, 2016	2.759M
March 31, 2016	3.436M
December 31, 2015	2.878M
September 30, 2015	2.818M
June 30, 2015	2.785M
March 31, 2015	2.638M
December 31, 2014	2.293M
September 30, 2014	1.966M
June 30, 2014	3.983M
March 31, 2014	1.885M
December 31, 2013	1.997M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

3.133M

Minimum

Dec 2019

6.37M

Maximum

Jun 2021

4.319M

Average

4.178M

Median

Sep 2022

SG&A Expense (Quarterly) Benchmarks